Aw Daryl Zheng Hao, Zhang Denzel Xugeng, Vignuzzi Marco
A*STAR Infectious Diseases Labs (A*STAR ID Labs), Agency for Science, Technology and Research (A*STAR), 8A Biomedical Grove, Immunos #05-13, Singapore, 138648, Singapore.
Infectious Diseases Translational Research Programme, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
NPJ Antimicrob Resist. 2025 Jun 9;3(1):54. doi: 10.1038/s44259-025-00125-z.
Antiviral resistance stemming from rapid viral evolution and adaptation is a major challenge faced in treating viral infections. Here, we describe the mechanisms and factors underlying antiviral resistance and their implications to future drug development. Current improvements to conventional methods provide viable options to overcome antiviral resistance. Ongoing efforts in developing new antiviral strategies are also discussed. Examples from across virology are used to illustrate how virus evolution and antiviral therapy influence each other.
由病毒快速进化和适应导致的抗病毒耐药性是治疗病毒感染所面临的一项重大挑战。在此,我们描述了抗病毒耐药性背后的机制和因素及其对未来药物研发的影响。传统方法的当前改进为克服抗病毒耐药性提供了可行的选择。还讨论了在开发新抗病毒策略方面正在进行的努力。来自病毒学各领域的实例用于说明病毒进化与抗病毒治疗是如何相互影响的。